P

Phialogics - The immune tolerance company

5 employees

Phialogics is focuses on developing next-generation biologics to balance the immune response in both acute and long-term inflammation.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Clinical Trials

Date founded

2021

Funding rounds raised

Total raised

$656K

from 1 investors over 1 rounds

P

Phialogics - The immune tolerance company raised $656K on April 19, 2023

Investors: High-Tech Gründerfonds

FAQ